Also Known As
Bremelanotide · Vyleesi
Overview
PT-141 works through the nervous system rather than the vascular system. FDA approved version (Vyleesi) exists for female HSDD.
Mechanism of Action
Activates melanocortin receptors (MC3R and MC4R) in the brain.
Quick Reference
Notes
May cause nausea. Allow 24+ hours between doses.
Dosing Protocol
Pharmacokinetics
Administration
Reconstitution
Special Instructions
Take 45+ minutes before desired effect. Do not use more than once per 24 hours. Maximum 8 doses per month (FDA guidance).
Warnings
Contraindications
Drug Interactions
Possible Side Effects
Legal & Regulatory
Pregnancy
Molecular Data
No sources available yet.
Related Peptides
No community data available yet. Be the first to add this peptide to your inventory!